In NSCLC, A2M expression was decreased in tumor cells compared to non-malignant lung tissue, while its receptor LRP1 was upregulated in the tumor stroma, indicating a potential compensatory mechanism. The gene discussed is A2M; the disease is non-small cell lung carcinoma.